Avidity Partners Management LP Cardiff Oncology, Inc. Transaction History

Avidity Partners Management LP

  • $445 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.01 - $7.58 $6.99 Million - $10.6 Million
-1,395,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$6.65 - $10.04 $7 Million - $10.6 Million
-1,052,700 Reduced 43.01%
1,395,000 $9.28 Million
Q1 2021

May 17, 2021
BUY
$9.1 - $19.57 $7.65 Million - $16.5 Million
840,700 Added 52.31%
2,447,700 $22.7 Million
Q4 2020

Feb 16, 2021
BUY
$12.02 - $24.71 $19.3 Million - $39.7 Million
1,607,000 New
1,607,000 $28.9 Million

Others Institutions Holding CRDF

# of Institutions
122
Shares Held
29.5M
Call Options Held
900K
Put Options Held
234K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $104M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email